MedTrace Logo

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

NCT00825617 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2009-01-21

No results posted yet for this study

Summary

Several studies have demonstrated that Turner Syndrome patients have elevated liver enzymes readily suppressible by a short course of HRT. We wanted to estimated quantitative liver functions in a young group of Turner syndrome patients compared to a healthy control group.

Conditions

  • Turner Syndrome

Interventions

DRUG

Hormone replacement therapy

Women with TS were treated with oral hormone substitution consisting of 2 mg 17β-estradiol/day for days 1-12, 2 mg 17β-estradiol/day and 1 mg norethisterone acetate/day for days 13-22 and 1 mg 17β-estradiol/day for days 23-28 (Trisekvens, Novo Nordisk A/S, Bagsværd, Denmark)

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • J S Christíansen, Professor · Medical departmnet M, Aarhus University Hospital, NBG, Denamrk,

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-10-31
Primary Completion
1999-10-31
Completion
2000-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00825617 on ClinicalTrials.gov